Purpose of the Screening
- Determine if the pregnant woman has pre-existing immunity.
- Detect recent infections that could impact fetal health.
- Assess the risk of fetal anemia or hydrops fetalis.
Parvovirus B19 screening is essential for pregnant women to safeguard fetal health against severe anemia. Early detection of IgG and IgM antibodies helps assess immunity and prevent potential pregnancy complications effectively.
Scientific name: Parvovirus B19 Antibody Screening (IgG & IgM)
A laboratory blood test measuring IgG and IgM antibodies to detect current or past Parvovirus B19 infection. This screening is crucial for monitoring fetal well-being and preventing potential fetal anemia risks.